Skip to Content

Treace Medical Concepts, Inc.

Securities Class Action

  • Date:
  • 10/28/2024
  • Company Name:
  • Treace Medical Concepts, Inc.
  • Stock Symbol:
  • TMCI
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ:TMCI) on behalf of Treace stockholders. Our investigation concerns whether Treace has violated the federal securities laws and/or engaged in other unlawful business practices.

On May 7, 2024 Treace Medical Concepts Inc. announced Q1 2024 financial results that met revenue estimates but lowered its guidance for the full year 2024 blaming it on "competitive pressure in its business."
 
Following this news, Treace's stock price fell by $6.95 per share, or approximately 62% on the same day.
 
If you purchased or otherwise acquired Treace shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Treace Medical Concepts. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: